Long-acting injectables help patients overcome stigma and adherence barriers in HIV care, explained Matthew H. Herrmann, MD, AAHIVS.
Matthew H. Herrmann, MD
Advertisement
Matthew H. Herrmann, MD, AAHIVS, is an infectious diseases specialist and internist, chief medical and research officer, and managing director at Pacific Oaks Medical Group.
Articles by Matthew H. Herrmann, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
2
Inside Myeloma’s Evolution From Death Sentence to Cure
3
Evolocumab Cuts Death Risk for a First Heart Attack or Stroke
4
FDA Approves Ropeginterferon Alfa-2b in Essential Thrombocythemia
5